scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicIndian drugs

Topic: Indian drugs

Indian car drivers, rising rage and the evolution of ‘hit and run’ culture

If Sanjeev Nanda and his BMW represented the entitled carelessness of wealth, today’s drivers represent its weaponised rage.

36 drugs to treat cancer, rare diseases exempted from basic customs duty in Union Budget 2025

Lakhs of patients are likely to benefit from this move as some of these drugs were exorbitant to procure.

India has a substandard, fake drugs problem. Lack of recall law, scrutiny is making matters worse

Underlining need for more accountability, experts also stress that govt data does not include fixed dose combination drugs, which account for over 40% of drugs sold in India.

ICMR calls for development of local drugs for rare diseases, offers assistance in clinical research

The medical research body aims to encourage domestic companies to develop cost-effective treatments for rare conditions, such as spinal muscular atrophy, Gaucher disease, among others.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Regulatory actions taken against 105 pharma companies, says health minister Mansukh Mandaviya

The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas.

WHO says 20 ‘contaminated’ drugs from Indian & Indonesian makers under scanner

WHO spokesperson says instances of contaminated drugs being found in 6 countries warranted Medical Product Alerts & that it takes reports of substandard medical products seriously.

‘Feeding cough syrup seems like Russian roulette’—new book exposes drug regulation in India

Dinesh S. Thakur and Prashant Reddy tapped into the nitty gritty of drug regulation, cough syrups and medicines in India at the launch of their book ‘Truth Pill’ in Delhi.

How Delhi Police’s war against drugs saved India from becoming another Colombia

In ‘Khaki in Dust Storm’, former DGP Amod K. Kanth revisits the 1980s and 1990s when India witnessed riots, political assassinations & growing culture of drug abuse.

Trump’s ‘Buy American First’ order will actually favour India — drug export body tells govt

Pharmexcil has told Modi govt that Indian generics constitute 10% of the US generic market in value terms & the order may give Indian drugmakers a chance to capture more.

On Camera

Eight journalists, four states and 1 UT—how ThePrint covered 2026 Assembly elections

As I read through the reports by these journalists, it became clear that ThePrint’s coverage was more about depth than breadth.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.